Recently, administration of BDNF was shown to increase the number and length of cultured podocyte processes, and also improved glomerular damage by repairing podocyte injury in a mouse model of focal segmental glomerulosclerosis [26]. This evidence concerns the gene BDNF and focal segmental glomerulosclerosis.